In a clinical trial, the supplementation with a combination of vitamins D, C and E remarkably reduced the serum levels of protein carbonyl, high-sensitivity C-Reactive Protein and TGF-β in IPF patients (Yavari et al., 2022). This evidence concerns the gene CRP and idiopathic pulmonary fibrosis.